Literature DB >> 11672822

Structural and functional heterogeneity of naturally occurring hepatitis B virus variants.

M R Burda1, S Günther, M Dandri, H Will, J Petersen.   

Abstract

Most organisms have developed sophisticated machineries to preserve their genomic integrity. On the contrary hepatitis B virus (HBV), like a lot of other viruses can undergo rapid and drastic sequence changes, especially if the virus has to cope with natural or therapy induced antiviral mechanisms in the host. Here, we try to summarize possible implications for the molecular pathogenesis of HBV based on the extensive research on the genetic variants of HBV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672822     DOI: 10.1016/s0166-3542(01)00177-2

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

Review 1.  Hepatitis B virus taxonomy and hepatitis B virus genotypes.

Authors:  Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients.

Authors:  Yin-Ping Lu; Tao Guo; Bao-Ju Wang; Ji-Hua Dong; Jian-Fang Zhu; Zhao Liu; Meng-Ji Lu; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

3.  A mutation specific polymerase chain reaction for detecting hepatitis B virus genome mutations at nt551.

Authors:  Chun-Ling Ma; De-Xing Fang; Hua-Biao Chen; Fa-Qing Li; Hui-Ying Jin; Su-Qin Li; Wei-Guo Tan
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

4.  Seroprevalence of hepatitis B and C genotypes among young apparently healthy females of karachi-pakistan.

Authors:  St Hakim; Su Kazmi; O Bagasra
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

5.  Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Authors:  Faseeha Noordeen; Catherine A Scougall; Arend Grosse; Qiao Qiao; Behzad B Ajilian; Georget Reaiche-Miller; John Finnie; Melanie Werner; Ruth Broering; Joerg F Schlaak; Andrew Vaillant; Allison R Jilbert
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

6.  Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.

Authors:  Mamun Al-Mahtab; Michel Bazinet; Andrew Vaillant
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.